US to Soon Approve Pfizer Booster Shot for Children Aged 5-11
[Asia Economy New York=Special Correspondent Joselgina] According to the New York Times (NYT) on the 17th, U.S. health authorities are expected to approve Pfizer-BioNTech's COVID-19 vaccine booster shot for children aged 5 to 11 as early as the 18th (local time).
According to the report, pharmaceutical companies Pfizer and BioNTech submitted an application for the use of the booster shot to the U.S. Food and Drug Administration (FDA) last month. The application included data showing that children aged 5 to 11 who received a third dose of the Pfizer vaccine exhibited stronger protection.
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- New Zealand to Cut 8,700 Civil Servants...14% Reduction Deemed 'Unsustainable and Unviable'
- Room Prices Soar from 60,000 to 760,000 Won and Sudden Cancellations: "We Won't Even Buy Water in Busan" — BTS Fans Outraged
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Currently, in the U.S., vaccination among children is cautious due to the lower risk of severe illness from COVID-19 infection and concerns about side effects. According to the U.S. Centers for Disease Control and Prevention (CDC), only 28.8% of the 28 million children aged 5 to 11 in the U.S. have completed the second dose.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing 90 Degrees These Days Actually Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
